Skip to main navigation Skip to search Skip to main content

PsyCog: A computerised mini battery for assessing cognition in psychosis

  • PSYSCAN Consortium
  • University of Oxford
  • King's College London
  • Karolinska Institutet
  • University Hospital Center
  • Cambridge Cognition Ltd
  • Oxford Health NHS Foundation Trust
  • Beth Israel Deaconess Medical Center
  • University College London
  • Department of Psychiatry
  • University Medical Centre Utrecht
  • Hospital Universitario Basurto
  • University of Amsterdam
  • Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM)
  • Hospital Universitario Virgen del Rocío
  • University of Copenhagen
  • University of Copenhagen
  • University of Edinburgh
  • Heidelberg University
  • Maastricht University Medical Centre
  • Hospital General Universitario Gregorio Marañón
  • Philipps-University
  • National Centre of Excellence in Youth Mental Health
  • Centre for Youth Mental Health
  • Second University of Naples
  • Universidade Federal de São Paulo
  • Seoul National University College of Medicine
  • Tel Aviv University
  • McGill University
  • Medical University Vienna
  • University of Zurich
  • Geneva University Hospitals
  • Icahn School of Medicine at Mount Sinai

Research output: Contribution to a Journal (Peer & Non Peer)Articlepeer-review

4 Citations (Scopus)

Abstract

Despite the functional impact of cognitive deficit in people with psychosis, objective cognitive assessment is not typically part of routine clinical care. This is partly due to the length of traditional assessments and the need for a highly trained administrator. Brief, automated computerised assessments could help to address this issue. We present data from an evaluation of PsyCog, a computerised, non-verbal, mini battery of cognitive tests. Healthy Control (HC) (N = 135), Clinical High Risk (CHR) (N = 233), and First Episode Psychosis (FEP) (N = 301) participants from a multi-centre prospective study were assessed at baseline, 6 months, and 12 months. PsyCog was used to assess cognitive performance at baseline and at up to two follow-up timepoints. Mean total testing time was 35.95 min (SD = 2.87). Relative to HCs, effect sizes of performance impairments were medium to large in FEP patients (composite score G = 1.21, subtest range = 0.52–0.88) and small to medium in CHR patients (composite score G = 0.59, subtest range = 0.18–0.49). Site effects were minimal, and test-retest reliability of the PsyCog composite was good (ICC = 0.82–0.89), though some practice effects and differences in data completion between groups were found. The present implementation of PsyCog shows it to be a useful tool for assessing cognitive function in people with psychosis. Computerised cognitive assessments have the potential to facilitate the evaluation of cognition in psychosis in both research and in clinical care, though caution should still be taken in terms of implementation and study design.

Original languageEnglish
Article number100310
JournalSchizophrenia Research: Cognition
Volume37
DOIs
Publication statusPublished - Sept 2024

Keywords

  • Clinical high risk for psychosis
  • Cognition
  • First episode psychosis
  • Psychosis

Fingerprint

Dive into the research topics of 'PsyCog: A computerised mini battery for assessing cognition in psychosis'. Together they form a unique fingerprint.

Cite this